APA Group

APA

APA Group engages in the business of owning, managing, and operating diverse portfolios of gas, electricity, solar, and wind assets. The company is headquartered in Sydney, New South Wales. The company went IPO on 2000-06-13. The firm's activities include gas transportation and storage, gas distribution, asset management, and renewable and gas-fired power generation. Its segments include energy infrastructure, asset management and energy investments. The firm owns energy infrastructure assets across gas transmission, compression, processing, storage and electricity generation (gas and renewables) and transmission. The asset management segment includes the provision of asset management and operating services for third parties and majority of the Company's energy investments. The energy investments segment includes interests in energy infrastructure investments. Its gas storage facilities include Mondarra Gas Storage and Processing Facility, and Dandenong Lng Gas Storage Facility. The firm's other energy services include wind and solar farms, electricity interconnectors and gas-fired power generation.

ANZ Group Holdings Limited

ANZ

ANZ Group Holdings Ltd. operates as a non-operating holding company. The company operates in six divisions: Australia Retail, Australia Commercial, Institutional, New Zealand, Pacific, and Group Center. The Australia Retail division offers a range of banking services, such as home loans, deposits, credit cards and personal loans. The company also offers digital and Internet banking and phone banking. The Australia Commercial division provides a full range of banking products and financial services, including asset financing, across customer segments: small business owners and medium commercial customers. The Institutional division services government, global institutional and corporate customers across Australia, New Zealand and International. The New Zealand division provides personal banking and wealth management services. The Pacific division provides retail products for traditional relationship banking. The Group center supports the operating divisions, including technology, property, and risk management.

BHP Group Limited

BHP

BHP Group Ltd. engages in the exploration, development, production and processing of iron ore, metallurgical coal, and copper. The company is headquartered in Melbourne, Victoria and currently employs 40,981 full-time employees. The firm is a producer of commodities, including iron ore, copper, nickel, potash and metallurgical (steelmaking) coal. The company is focused on offering a range of resources, which provides copper for renewable energy; nickel for electric vehicles; potash for sustainable farming, and iron ore and metallurgical coal for the steel needed for global infrastructure and the energy transition. Its segments include Copper, Iron Ore, and Coal. Its Copper segment is engaged in mining of copper, silver, zinc, molybdenum, uranium, and gold. Its Iron Ore segment is engaged in mining of iron ore. Its Coal segment is engaged in mining of metallurgical coal and energy coal. The firm is also focused on operating Olympic Dam, Prominent Hill, and Carrapateena underground copper-gold mines in South Australia. Its operations are situated in Australia, Europe, China, Japan, India, South Korea, rest of Asia, North America, South America, and others.

Clinuvel Pharmaceuticals Limited

CUV

Clinuvel Pharmaceuticals Ltd. operates as a biopharmaceutical company. The company is headquartered in Melbourne, Victoria. The company went IPO on 2001-02-13. The firm is focused on developing and commercializing treatments for patients with genetic, metabolic, systemic, and life-threatening, acute disorders, as well as healthcare solutions for specialized populations. Its lead therapy, SCENESSE (afamelanotide 16mg), is approved for commercial distribution in Europe, the USA, Israel, and Australia as the first systemic photoprotective drug for the prevention of phototoxicity (anaphylactoid reactions and burns) in adult patients with erythropoietic protoporphyria (EPP). The Company’s pharmaceuticals product development includes PRENUMBRA and NEURACTHEL. Its PhotoCosmetics product development includes CYACELLE and DNA Repair Assist and Melanogenesis. PRENUMBRA is a formulation of afamelanotide designed to provide a flexible dose in identified patient groups. NEURACTHEL is a novel formulation of the melanocortin adrenocorticotropic hormone (ACTH).

Adrad Holdings Limited

AHL

Adrad Holdings Ltd. manufactures and supplies radiators for motor vehicles. The firm designs and manufactures heat transfer solutions for OE customers globally and the manufacture, importation and distribution of automotive parts for the aftermarket. The firm operates through two segments: Heat Transfer Solutions and Adrad Distribution. The Heat Transfer Solutions segment designs and manufactures industrial cooling solutions for use in road transport and heavy vehicles, mining, power generation, data centers and rail industries. Adrad Distribution segment imports and distributes radiators, mobile and stationary heat exchange products and a variety of automotive parts for the Australian and New Zealand automotive and industrial markets. The firm has facilities across Australia, New Zealand and Thailand, a number of which include warehousing, manufacturing and service facilities.